- Home
- RACE vs GSK Comparison
RACE vs GSK Comparison
Compare RACE & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RACE
- GSK
- Stock Information
- Founded
- RACE 1947
- GSK 1715
- Country
- RACE Italy
- GSK United Kingdom
- Employees
- RACE N/A
- GSK N/A
- Industry
- RACE Auto Manufacturing
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- RACE Consumer Discretionary
- GSK Health Care
- Exchange
- RACE Nasdaq
- GSK Nasdaq
- Market Cap
- RACE 90.1B
- GSK 74.6B
- IPO Year
- RACE 2015
- GSK N/A
- Fundamental
- Price
- RACE $430.84
- GSK $37.88
- Analyst Decision
- RACE Buy
- GSK Hold
- Analyst Count
- RACE 8
- GSK 4
- Target Price
- RACE $498.86
- GSK $47.00
- AVG Volume (30 Days)
- RACE 545.7K
- GSK 4.6M
- Earning Date
- RACE 05-06-2025
- GSK 04-30-2025
- Dividend Yield
- RACE 0.75%
- GSK 4.10%
- EPS Growth
- RACE 22.61
- GSK N/A
- EPS
- RACE 8.76
- GSK 0.78
- Revenue
- RACE $6,912,380,166.00
- GSK $39,280,393,592.00
- Revenue This Year
- RACE $9.20
- GSK $7.60
- Revenue Next Year
- RACE $10.78
- GSK $5.24
- P/E Ratio
- RACE $47.94
- GSK $23.95
- Revenue Growth
- RACE 11.83
- GSK 3.46
- 52 Week Low
- RACE $399.27
- GSK $31.72
- 52 Week High
- RACE $509.13
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- RACE 42.60
- GSK 44.79
- Support Level
- RACE $421.14
- GSK $37.76
- Resistance Level
- RACE $438.67
- GSK $38.98
- Average True Range (ATR)
- RACE 8.68
- GSK 0.57
- MACD
- RACE -1.31
- GSK -0.28
- Stochastic Oscillator
- RACE 52.68
- GSK 7.17
About RACE Ferrari N.V.
Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2023, the company sold 13,663 vehicles at an average price over EUR 400,000 with more than 70% of its vehicles being sold to existing Ferrari clients. Eighty-six percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2023, the Europe, Middle East, and Africa region accounted for 48% of revenue, the Americas was 30%, mainland China, Hong Kong, and Taiwan was 10%, and the rest of Asia was 13%.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.